Sunshine Heart gains two experts for US C-Pulse trial
09:02, Thursday, February 22, 2007
Sydney - Thursday - February 22: (RWE Aust Business News) -
Sunshine Heart (ASX:SHC) said Dr William T Abraham of Ohio State
University and Dr Patrick M McCarthy of Northwestern University, Chicago,
have agreed to become the co-principal investigators for the C-Pulse
feasibility trial the United States.
The appointment of Drs Abraham and McCarthy continues Sunshine
Heart's progress towards commencing the multi-centre trial during 2007
following the positive meeting with the FDA (United States Food and Drug
Administration).
Sunshine Heart shares were last traded at 20c.
- Forums
- ASX - By Stock
- VCR
- sunshine
VCR
ventracor limited
sunshine
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.